Norwest Venture Partners Xiv, Lp Impel Pharmaceuticals Inc (IMPL) insider trading activity

IMPL Quotes by TradingView

Norwest Venture Partners Xiv, LP is > 10% Shareholder of IMPEL PHARMACEUTICALS INC. Currently has a direct ownership of 3.08 Million shares of IMPL, which is worth approximately $61,543. The most recent transaction as insider was on Apr 27, 2021, when has been sold 825,000 shares (Common Stock) at a price of $15.0 per share, resulting in proceeds of $12,375,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.08M
0% 3M change
0% 12M change
Total Value Held $61,543

Norwest Venture Partners XIV, LP Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 27 2021
BUY
Open market or private purchase
$12,375,000 $15.0 p/Share
825,000 Added 21.14%
3,077,198 Common Stock
Apr 27 2021
BUY
Conversion of derivative security
$15,202,336 $6.75 p/Share
2,252,198 Added 50.0%
2,252,198 Common Stock
NVP

Norwest Venture Partners Xiv, LP

> 10% Shareholder
Palo Alto, CA

Track Institutional and Insider Activities on IMPL

Follow IMPEL PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMPL shares.

Notify only if

Insider Trading

Get notified when an Impel Pharmaceuticals Inc insider buys or sells IMPL shares.

Notify only if

News

Receive news related to IMPEL PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMPL